225 related articles for article (PubMed ID: 9648450)
1. [Hyperlipidemia and arteriosclerosis].
Mabuchi H
Nihon Naika Gakkai Zasshi; 1998 May; 87(5):950-7. PubMed ID: 9648450
[No Abstract] [Full Text] [Related]
2. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia].
Martínez-Castelao A
Med Clin (Barc); 1995 Nov; 105(18):719. PubMed ID: 8538262
[No Abstract] [Full Text] [Related]
3. [Cardiovascular pharmacology (VIII). The role of HMG CoA reductase inhibitors in the current treatment of hyperlipidemias].
Carmena R
Rev Esp Cardiol; 1995 Jan; 48(1):59-65. PubMed ID: 7878284
[No Abstract] [Full Text] [Related]
4. The beneficial effects of HMG-coenzyme A reductase inhibitor in the primary and secondary prevention of atherosclerosis in the coronaries.
Drown DJ
Prog Cardiovasc Nurs; 1996; 11(2):38-9. PubMed ID: 8718962
[No Abstract] [Full Text] [Related]
5. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
Motz W
MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
[No Abstract] [Full Text] [Related]
6. Variable influence of statins on isoprostanes in hyperlipidemia.
Sinzinger H; Oguogho A
Adv Exp Med Biol; 2003; 525():209-12. PubMed ID: 12751770
[No Abstract] [Full Text] [Related]
7. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
Elam MB; Cushman W; Applegate WB; Heimberg M
Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876
[No Abstract] [Full Text] [Related]
8. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
9. [Primary and secondary prevention of coronary disease by statins].
Ferrières J
Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
[TBL] [Abstract][Full Text] [Related]
10. Review of primary and secondary prevention trials with lovastatin, pravastatin, and simvastatin.
Gotto AM
Am J Cardiol; 2005 Sep; 96(5A):34F-38F. PubMed ID: 16126021
[TBL] [Abstract][Full Text] [Related]
11. Coronary events with lipid-lowering therapy: the AFCAPS/TexCAPS trial. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Kandzari DE; Goldschmidt-Clermont PJ
JAMA; 1999 Feb; 281(5):415; author reply 417-9. PubMed ID: 9952193
[No Abstract] [Full Text] [Related]
12. [Statin treatment in type 2 diabetes. Is it a must today?].
Faust M
MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527
[No Abstract] [Full Text] [Related]
13. Treatment of hyperlipidemia in cardiac transplant recipients.
Bilchick KC; Henrikson CA; Skojec D; Kasper EK; Blumenthal RS
Am Heart J; 2004 Aug; 148(2):200-10. PubMed ID: 15308989
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of dyslipidemia in the secondary prevention of coronary artery disease].
Syvänne M
Duodecim; 1998; 114(15):1503-8. PubMed ID: 11552239
[No Abstract] [Full Text] [Related]
15. Updated guidelines support even lower cholesterol levels for at-risk patients.
Levenson D
Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
[No Abstract] [Full Text] [Related]
16. Clinical aspects of dyslipidemia.
Kashyap M
Manag Care; 2001 Nov; 10(11 Suppl):4-9; discussion 19-24. PubMed ID: 11761628
[No Abstract] [Full Text] [Related]
17. [Use of statins in primary prevention: from the theoretical presuppositions to complex scenarios of the real world].
Poli A; Menotti A
G Ital Cardiol; 1999 Oct; 29(10):1123-30. PubMed ID: 10546121
[No Abstract] [Full Text] [Related]
18. [Treatment with statins for the reduction of cardiovascular risk].
Chiariello M
Ital Heart J Suppl; 2001 Mar; 2(3):221-3. PubMed ID: 11307779
[No Abstract] [Full Text] [Related]
19. [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
Sudhop T; von Bergmann K
MMW Fortschr Med; 2003 May; 145(21):19. PubMed ID: 12845862
[No Abstract] [Full Text] [Related]
20. [Lipid metabolism and risk of myocardial infarction -- new findings and implications for treatment].
Cullen P; Schulte H; Assmann G
Dtsch Med Wochenschr; 2005 Sep; 130(39):2220-5. PubMed ID: 16189760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
